MRKR earnings
Marker Therapeutics (MRKR) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
MRKR earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | -0.10 | -0.12 | 14.29% | – |
| Q2 2026 | Aug 14, 2026 | -0.09 | -0.13 | 29.13% | $700.00K |
| Q1 2026 | May 15, 2026 | -0.16 | -0.18 | 11.11% | $800.00K |
| Q4 2025 | Mar 18, 2026 | -0.10 | -0.21 | 52.38% | $1.10M |
| Q3 2025 | Nov 13, 2025 | -0.12 | -0.36 | 66.67% | $1.23M |
| Q2 2025 | Aug 14, 2025 | -0.29 | -0.30 | 4.56% | $861.18K |
| Q1 2025 | May 15, 2025 | -0.40 | – | – | $349.10K |
| Q4 2024 | Mar 31, 2025 | -0.42 | -0.22 | -90.91% | $2.25M |
| Q3 2024 | Nov 14, 2024 | -0.26 | -0.39 | 33.33% | $1.93M |
| Q2 2024 | Aug 14, 2024 | -0.29 | -0.43 | 32.56% | $1.17M |
| Q1 2024 | May 15, 2024 | -0.27 | -0.25 | -8.00% | $1.24M |
| Q3 2023 | Nov 9, 2023 | -0.34 | -0.90 | 62.22% | $257.61K |
| Q2 2023 | Aug 14, 2023 | -0.47 | -0.80 | 41.25% | $762.66K |
| Q1 2023 | May 16, 2023 | -0.57 | 0.80 | -171.25% | $1.23M |
| Q3 2022 | Nov 10, 2022 | -0.80 | – | – | $999.57K |
- MRKR beat EPS estimates in 10 of its last 13 reports.
Updated 2026-11-20 21:45 UTC